Abstract
This review article is intended to show and understand psychosocial factors in patients with chronic kidney disease (CKD) including end-stage renal disease (ESRD) on renal replacement therapy. These patients suffered from many psychosocial factors such as depression, sleep disorder, and chronic pain, etc. The prevalence of major depression or a defined psychiatric illness in ESRD patients is not clearly defined, but is roughly estimated between 5% and 50%. Unfortunately many sufferers do not seek treatment, and of those who do, significant numbers are improperly diagnosed or are not appropriately treated. They should be managed by psychiatric medication and interview, because depression could affect medical outcomes in ESRD patients through several mechanisms. Sleep disorders are common in ESRD patients treated with dialysis and are associated with patients' perceptions of quality of life, assessed by diverse measures, as well as depressive mood. Although pain has been considered as a problem for ESRD patients for more than 20 years, few studies exist on this subject. Pain appears to be an undervalued problem for ESRD patients. These psychosocial factors could affect morbidity, mortality and life quality in CKD and ESRD patients. The physicians, especially managing CKD patients, need to consider these factors.
References
1. ESRD Registry Committee. Current renal replacement therapy in Korea - Insan Memorial Dialysis Registry. In : Proceedings of the 33rd Annual Autumn Meeting of the Korean Society of Nephrology; 2013 Oct 12; Kimdaejung Convention Center, Gwangju. Korean Society of Nephrology;2013.
2. Kim TH. Social and economic burden of chronic kidney disease in Korea. In : Proceedings of the 32nd Annual Autumn Meeting of the Korean Society of Nephrology; 2012.
3. Cassano P, Fava M. Depression and public health: an overview. J Psychosom Res. 2002; 53:849–857.
4. Sheikh JI, Cassidy EL, Doraiswamy PM, Salomon RM, Hornig M, Holland PJ, et al. Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness. J Am Geriatr Soc. 2004; 52:86–92.
5. Cohen-Cole SA, Kaufman KG. Major depression in physical illness: diagnosis, prevalence, and antidepressant treatment (a ten year review: 1982-1992). Depression. 1993; 1:181–204.
6. Finkelstein FO, Finkelstein SH. Depression in chronic dialysis patients: assessment and treatment. Nephrol Dial Transplant. 2000; 15:1911–1913.
8. Kim JA, Lee YK, Huh WS, Kim YG, Kim DJ, Oh HY, et al. Analysis of depression in continuous ambulatory peritoneal dialysis patients. J Korean Med Sci. 2002; 17:790–794.
9. Wuerth D, Finkelstein SH, Kliger AS, Finkelstein FO. Chronic peritoneal dialysis patients diagnosed with clinical depression: results of pharmacologic therapy. Semin Dial. 2003; 16:424–427.
10. Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Alleyne S, Cruz I, et al. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int. 2000; 57:2093–2098.
11. Mulrow CD, Williams JW Jr, Chiquette E, Aguilar C, Hitchcock-Noel P, Lee S, et al. Efficacy of newer medications for treating depression in primary care patients. Am J Med. 2000; 108:54–64.
12. Kennedy SH, Craven JL, Rodin GM. Major depression in renal dialysis patients: an open trial of antidepressant therapy. J Clin Psychiatry. 1989; 50:60–63.
13. Streltzer J. Diagnostic and treatment considerations in depressed dialysis patients. Clin Exp Dial Apheresis. 1983; 7:257–274.
14. Wuerth D, Finkelstein SH, Ciarcia J, Peterson R, Kliger AS, Finkelstein FO. Identification and treatment of depression in a cohort of patients maintained on chronic peritoneal dialysis. Am J Kidney Dis. 2001; 37:1011–1017.
15. Israel M. Depression in dialysis patients: a review of psychological factors. Can J Psychiatry. 1986; 31:445–451.
16. Levenson JL, Glocheski S. Psychological factors affecting end-stage renal disease. A review. Psychosomatics. 1991; 32:382–389.
17. Kimmel PL, Weihs K, Peterson RA. Survival in hemodialysis patients: the role of depression. J Am Soc Nephrol. 1993; 4:12–27.
18. Kimmel PL. Depression in patients with chronic renal disease: what we know and what we need to know. J Psychosom Res. 2002; 53:951–956.
19. Smith MD, Hong BA, Robson AM. Diagnosis of depression in patients with end-stage renal disease. Comparative analysis. Am J Med. 1985; 79:160–166.
20. Craven JL, Rodin GM, Littlefield C. The Beck Depression Inventory as a screening device for major depression in renal dialysis patients. Int J Psychiatry Med. 1988; 18:365–374.
21. Lowry MR, Atcherson E. A short-term follow-up of patients with depressive disorder on entry into home dialysis training. J Affect Disord. 1980; 2:219–227.
22. Hinrichsen GA, Lieberman JA, Pollack S, Steinberg H. Depression in hemodialysis patients. Psychosomatics. 1989; 30:284–289.
23. Sacks CR, Peterson RA, Kimmel PL. Perception of illness and depression in chronic renal disease. Am J Kidney Dis. 1990; 15:31–39.
24. Kimmel PL, Patel SS, Peterson RA. Depression in African-American patients with kidney disease. J Natl Med Assoc. 2002; 94:92s–103s.
25. Kimmel PL, Peterson RA, Weihs KL, Shidler N, Simmens SJ, Alleyne S, et al. Dyadic relationship conflict, gender, and mortality in urban hemodialysis patients. J Am Soc Nephrol. 2000; 11:1518–1525.
26. Kurella M, Kimmel PL, Young BS, Chertow GM. Suicide in the United States end-stage renal disease program. J Am Soc Nephrol. 2005; 16:774–781.
27. Einwohner R, Bernardini J, Fried L, Piraino B. The effect of depressive symptoms on survival in peritoneal dialysis patients. Perit Dial Int. 2004; 24:256–263.
28. Hanly P. Sleep apnea and daytime sleepiness in end-stage renal disease. Semin Dial. 2004; 17:109–114.
29. Kimmel PL, Miller G, Mendelson WB. Sleep apnea syndrome in chronic renal disease. Am J Med. 1989; 86:308–314.
30. Kimmel PL. Go to bed and get a good night's sleep: you need your rest! Am J Kidney Dis. 2000; 35:1221–1223.
32. Zoccali C, Mallamaci F, Tripepi G. Sleep apnea in renal patients. J Am Soc Nephrol. 2001; 12:2854–2859.
33. Iliescu EA, Yeates KE, Holland DC. Quality of sleep in patients with chronic kidney disease. Nephrol Dial Transplant. 2004; 19:95–99.
34. Zoccali C, Mallamaci F, Tripepi G. Nocturnal hypoxemia: a neglected cardiovascular risk factor in end-stage renal disease? Blood Purif. 2002; 20:120–123.
35. Skevington SM. Investigating the relationship between pain and discomfort and quality of life, using the WHOQOL. Pain. 1998; 76:395–406.
36. Devins GM, Armstrong SJ, Mandin H, Paul LC, Hons RB, Burgess ED, et al. Recurrent pain, illness intrusiveness, and quality of life in end-stage renal disease. Pain. 1990; 42:279–285.
37. Bailie GR, Mason NA, Bragg-Gresham JL, Gillespie BW, Young EW. Analgesic prescription patterns among hemodialysis patients in the DOPPS: potential for underprescription. Kidney Int. 2004; 65:2419–2425.
38. Davison SN. Pain in hemodialysis patients: prevalence, cause, severity, and management. Am J Kidney Dis. 2003; 42:1239–1247.
40. Christensen AJ, Wiebe JS, Smith TW, Turner CW. Predictors of survival among hemodialysis patients: effect of perceived family support. Health Psychol. 1994; 13:521–525.
41. Goodwin PJ, Leszcz M, Ennis M, Koopmans J, Vincent L, Guther H, et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med. 2001; 345:1719–1726.
42. Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Alleyne S, Cruz I, et al. Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int. 1998; 54:245–254.